Hiraishi C, Matsui S, Kojima T, Sato R, Ando K, Fujimoto K
J Atheroscler Thromb. 2023; 31(1):81-89.
PMID: 37558461
PMC: 10776332.
DOI: 10.5551/jat.64261.
Xie Y, Qi H, Li B, Wen F, Zhang F, Guo C
Front Endocrinol (Lausanne). 2022; 13:1023919.
PMID: 36506069
PMC: 9727385.
DOI: 10.3389/fendo.2022.1023919.
Feng S, Zhao X, Wang Y, Wang Y, Chen G, Zhang S
Front Cardiovasc Med. 2022; 9:811317.
PMID: 35187127
PMC: 8855038.
DOI: 10.3389/fcvm.2022.811317.
Xuan L, Wang T, Dai H, Wang B, Xiang J, Wang S
J Lipid Res. 2020; 61(10):1320-1327.
PMID: 32703886
PMC: 7529054.
DOI: 10.1194/jlr.RA120000771.
Hari P, Khandelwal P, Smoyer W
Pediatr Nephrol. 2019; 35(9):1601-1619.
PMID: 31302760
DOI: 10.1007/s00467-019-04301-y.
Effect of atorvastatin on dyslipidemia and carotid intima-media thickness in children with refractory nephrotic syndrome: a randomized controlled trial.
Hari P, Khandelwal P, Satpathy A, Hari S, Thergaonkar R, Lakshmy R
Pediatr Nephrol. 2018; 33(12):2299-2309.
PMID: 30091061
DOI: 10.1007/s00467-018-4036-x.
The effect of cholesterol overload on mouse kidney and kidney-derived cells.
Honzumi S, Takeuchi M, Kurihara M, Fujiyoshi M, Uchida M, Watanabe K
Ren Fail. 2018; 40(1):43-50.
PMID: 29304720
PMC: 6014466.
DOI: 10.1080/0886022X.2017.1419974.
Dyslipidaemia in nephrotic syndrome: mechanisms and treatment.
Agrawal S, Zaritsky J, Fornoni A, Smoyer W
Nat Rev Nephrol. 2017; 14(1):57-70.
PMID: 29176657
PMC: 5770189.
DOI: 10.1038/nrneph.2017.155.
Statins and Renin Angiotensin System Inhibitors Dose-Dependently Protect Hypertensive Patients against Dialysis Risk.
Liu J, Hsu Y, Wu S
PLoS One. 2016; 11(9):e0162588.
PMID: 27632175
PMC: 5025231.
DOI: 10.1371/journal.pone.0162588.
Renal Lipotoxicity-Associated Inflammation and Insulin Resistance Affects Actin Cytoskeleton Organization in Podocytes.
Martinez-Garcia C, Izquierdo-Lahuerta A, Vivas Y, Velasco I, Yeo T, Chen S
PLoS One. 2015; 10(11):e0142291.
PMID: 26545114
PMC: 4636358.
DOI: 10.1371/journal.pone.0142291.
Therapeutic approaches to slowing the progression of diabetic nephropathy - is less best?.
Vivian E, Mannebach C
Drugs Context. 2014; 2013:212249.
PMID: 24432038
PMC: 3884747.
DOI: 10.7573/dic.212249.
Lipid-lowering agents for nephrotic syndrome.
Kong X, Yuan H, Fan J, Li Z, Wu T, Jiang L
Cochrane Database Syst Rev. 2013; (12):CD005425.
PMID: 24327265
PMC: 11683665.
DOI: 10.1002/14651858.CD005425.pub2.
Vitamin E and regression of hypercholesterolemia-induced oxidative stress in kidney.
Prasad K
Mol Cell Biochem. 2013; 385(1-2):17-21.
PMID: 24057088
DOI: 10.1007/s11010-013-1809-1.
Lipid abnormalities in chronic renal failure.
Bhagwat R, Joshi S, Salgia P, Sepaha A
Indian J Clin Biochem. 2012; 12(1):81-5.
PMID: 23100870
PMC: 3454047.
DOI: 10.1007/BF02867962.
Effects of statins on cardiorenal syndrome.
Yagi S, Aihara K, Ikeda Y, Akaike M, Sata M, Matsumoto T
Int J Vasc Med. 2012; 2012:162545.
PMID: 22792467
PMC: 3390040.
DOI: 10.1155/2012/162545.
Intensified inhibition of renin-angiotensin system: a way to improve renal protection?.
Cravedi P, Ruggenenti P, Remuzzi G
Curr Hypertens Rep. 2009; 11(2):118-24.
PMID: 19278601
DOI: 10.1007/s11906-009-0022-9.
Intensified inhibition of renin-angiotensin system: a way to improve renal protection?.
Cravedi P, Ruggenenti P, Remuzzi G
Curr Hypertens Rep. 2008; 9(5):430-6.
PMID: 18177592
DOI: 10.1007/s11906-007-0078-3.
A case of homozygous familial hypercholesterolemia with focal segmental glomerulosclerosis.
Elmaci A, Peru H, Akin F, Akcoren Z, Caglar M, Ozel A
Pediatr Nephrol. 2007; 22(10):1803-5.
PMID: 17636341
DOI: 10.1007/s00467-007-0534-y.
Clinical spectrum of chronic renal failure in the elderly: a hospital based study from eastern India.
Prakash J, Hota J, Singh S, Sharma O
Int Urol Nephrol. 2006; 38(3-4):821-7.
PMID: 17096077
DOI: 10.1007/s11255-006-9003-y.
Oral supplement of six selective amino acids arrest progression renal failure in uremic patients.
Yatzidis H
Int Urol Nephrol. 2005; 36(4):591-8.
PMID: 15787344
DOI: 10.1007/s11255-004-8782-2.
